Research Overview
Penn Ophthalmology is a pioneer in basic and clinical research, leading some of the most advanced ophthalmic research centers and initiatives in the world. The Department is a top recipient of National Eye Institute funding. Nearly all of the department's researchers are also practicing physicians, with specialized clinical knowledge.
Last year, Penn Ophthalmology faculty:
- Produced 140 publications
- Achieved a research impact (H-index) of 117
Members of the Department of Ophthalmology conduct a wide variety of clinical trials. To learn more about Penn Ophthalmology's most recent advances, check out the news page, including some of our featured research articles.
A Letter from the Vice Chair for Research
FM Kirby Center for Molecular Ophthalmology
Vrathasha Vrathasha Awarded Knights Templar Grant
3 Faculty Awarded Helen Keller Prize for Vision Research
Benjamin Kim MD Awarded NIH Grant
Dr. Cideciyan, Dr. Aleman Mark Innovation in Gene Therapy
Expansion to One uCity Square
Innovating Vision Science with the Vision Science Symposium
Jessica Morgan PhD Honored by Pfizer Ophthalmics
The K12 Clinician Vision Science Program
Ophthalmology Research Faculty
Please view the Department of Ophthalmology's acclaimed research faculty and their research interests on our faculty webpage.
Please view our research faculty's lectures at the 2nd inaugural Vision Science Symposium in 2024, available at this link.
Please view our research faculty's lectures at the 3rd inaugural Vision Science Symposium in 2025, available at this link.
Reversing Blindness with New FDA Approved Retinal Gene Therapy
The gene therapy, called Luxturna, was developed by Jean Bennett, MD, PhD, and Albert M. Maguire, MD.
Talk recorded by CureTalks on June 12, 2018 at 1 pm ET.